DDX17 and glioblastoma: Conversely, a significant negative correlation was found between DDX17 expression and immune infiltration in seventeen other cancer types, including GBM, GBMLGG, LGG, CESC, LAML, BRCA, STES, SARC, KIRP, UCEC, LUSC, THCA, SKCM-M, TGCT, PCPG, ACC, and BLCA (Fig. 4A–T), implying that DDX17 might suppress immune infiltration, potentially contributing to immune evasion in these tumors.